From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q3 2016 call → NOWe need answer only YES or NO. Need analyze transcript. Need determine if management describes recently crossed into approved/specified/listed etc. buyer system, with future volume ahead. Let's parse. Transcript mentions American Girl expansion distribution: "initial shipping to support our new exclusive store within the store partnership with Toy [ph]." "new retail execution" "new franchise licensing agreement to expand the brand into Middle East." Also "initial set of our expanded distribution strategy" "signing of a new international licensing opportunity." This sounds like new distribution partnerships, but is that "approved/specified/listed" inside buyer's purchasing system? It is a retail store-within-store partnership, exclusive. Could be a distribution channel, not necessarily a formulary-like listing. Need see if management conveys that this access is new and future volume ahead. They say "initial shipping" and "look to see continued progress in fourth quarter." But is this a "meaningful portion of future business can arrive without discrete selling event"? Retail store-within-store partnership is a distribution arrangement, but each sale still occurs to consumers; not a procurement pathway. Also "new franchise licensing agreement" for Middle East. That's licensing, not product sales. Other mentions: "expanded distribution strategy" for American Girl. "new exclusive store within the store partnership with Toy [ph]" (likely Toys R Us). This is a retail distribution deal, not a buyer-side approved supplier list. The question asks about company being placed into buyer's purchasing/reimbursement/formulary/specification/procurement/network/catalog/program systems. Retail store-within-store is a sales channel, not a procurement system. Also "new international licensing opportunity" is licensing. Any other? "Toy Box" TV show? No. "DC Superhero Girls" etc. No. "Barbie" shelf space gains: "increased retailer confidence in the brand as they restock and expand our recent shelf space." That's ordinary retail shelf space, not a system where purchases happen without selling. Each order still negotiated. "American Girl" with "new exclusive store within the store partnership" could be considered a "program" but it's a retail partnership, not a reimbursement/formulary. The essential point is buying no longer re-argued each time because company inside pathway.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.